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The introduction of new imaging techniques offers the
opportunity for identification of the presence of subclinical
atherosclerosis in asymptomatic persons. The ability to
measure the extent of subclinical atherosclerosis could be of
value in the selection of persons for more intensive primary
prevention of coronary heart disease (CHD). Techniques
are currently available for measuring subclinical atheroscle-
rosis in peripheral arteries (ankle/brachial blood pressure
index), carotid arteries (intimal medial thickness measured
by B-mode sonography) and coronary arteries (coronary
calcium measured by computed tomography [CT]) (1). In
addition, the finding of myocardial ischemia by a variety of
tests usually indicates the presence of advanced coronary
atherosclerosis (1). A question of considerable importance
for primary prevention is how the information attained
through the identification of subclinical atherosclerosis or
myocardial ischemia can be used in risk assessment and in
the selection of patients for more intensive risk reduction
therapy for primary prevention.
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The most widely used technique for detecting subclinical
coronary atherosclerosis is measurement of coronary calcium
scores by electron beam computed tomography (EBCT)
(2,3). Coronary calcium scores also can be measured by
spiral CT, although this method is not widely employed at
present. The two methods for measuring coronary calcium
scores have not been adequately compared. Regardless, both
autopsy and angiographic studies show that the extent of
calcium accumulation in coronary arteries correlates strongly
with the severity of coronary atherosclerosis (4–9). Thus,
the coronary calcium score gives a fairly good estimate of the
total coronary plaque burden. Follow-up studies of patients
undergoing coronary angiography reveal that the coronary
plaque burden also is a good predictor of future coronary
events (10–12). Thus, coronary calcium scores probably
carry predictive power for future major coronary events.
Preliminary studies indeed provide support for predictive
power of coronary calcium (13,14).
To date, however, the full predictive potential of coronary
calcium for future coronary events remains unknown. More-
over, the extent to which coronary calcium predicts inde-
pendently of standard risk factors—cigarette smoking, hy-
pertension, elevated low density lipoprotein cholesterol, low
high density lipoprotein (HDL) cholesterol, and family
history of premature CHD—has not been resolved. Ac-
cording to some investigators (15), estimates of coronary
calcium scores should not be used in risk assessment for
selection of persons for primary prevention until their
independent power has been accurately determined. Cer-
tainly the standard risk factors independently predict future
coronary events and are useful in selection of persons for
preventive intervention (16). Their power to predict, nev-
ertheless, is limited; if new risk factors, such as subclinical
atherosclerosis, could enhance risk prediction, selection of
patients for intervention would be improved.
Some investigators take a completely different view of the
utility of subclinical atherosclerosis to predict coronary
events. Such a view is apparent in the article in this issue of
the Journal by Hecht and Superko (17); these investigators
used EBCT in asymptomatic women to detect “coronary
artery disease” (CAD) or subclinical atherosclerosis. They
take the position that standard risk factors are of little value
in risk prediction, whereas coronary calcium is robust and
should essentially replace standard risk factors in the iden-
tification of patients for medical primary prevention. In the
opinion of other investigators (15), however, such a position
is not founded on a solid base of scientific evidence. Because
these different views of the value of coronary calcium as a
risk indicator are almost diametrically opposed, it may be
worthwhile to examine some of the underlying issues.
One issue has to do with the meaning of two different
terms: CAD and CHD. In the cardiology world, these two
terms often are used interchangeably. The result is consid-
erable confusion that could be avoided by recognizing a
distinction. Unfortunately, two different meanings are ap-
plied to CAD: 1) coronary atherosclerosis, and 2) heart
disease resulting from coronary atherosclerosis. The confu-
sion could be easily eliminated by letting CAD mean
coronary atherosclerosis and allowing CHD to refer to the
heart disease that is the product of coronary atherosclerosis.
By this distinction, CHD can refer to manifest disease of
the heart—myocardial infarction, stable and unstable angina
and myocardial dysfunction.
It is also important to distinguish between obstructive
coronary atherosclerosis causing angina pectoris and coro-
nary plaque rupture producing acute coronary syndromes
(unstable angina pectoris and myocardial infarction). Cor-
onary angiography is useful for identifying the former.
Conversely, coronary calcium measurements have limited
utility for identifying obstructive coronary atherosclerosis,
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but may be useful for the latter. The prime question
concerns their predictive power for acute coronary syn-
dromes.
Hecht and Superko (17) equate coronary calcium with
CAD. In essence, they transform coronary calcium into a
disease that needs treatment. This concept is not far
removed from current practice of many cardiologists. For
example, the finding of a partially blocked coronary artery by
angiography often is a call for action, that is, coronary
angioplasty. More recently, in the hands of some physicians,
the finding of coronary calcium likewise has been a call for
action, namely, for evaluation of coronary arteries by an-
giography followed in some cases by coronary angioplasty.
This frequently unwarranted sequence of events is what led
the American College of Cardiology (ACC)/American Heart
Association (AHA) (3) to warn against widespread screen-
ing of EBCT to detect CAD in asymptomatic patients.
Hecht and Superko (17) give an added twist to the story.
They wisely do not propose using coronary calcium to
identify patients who need coronary angiography. Never-
theless, they do equate coronary calcium with CAD and
suggest that its presence calls for aggressive medical therapy
for risk reduction. Presumably this would mean the use of
statins and aspirin for most asymptomatic patients found to
have detectable coronary calcium by EBCT.
In their report, Hecht and Superko (17) suggest that the
National Cholesterol Education Program (NCEP) program
is flawed in risk assessment because the standard risk factors
are not robust enough to accurately predict coronary ath-
erosclerosis (CAD). However, they fail to note that the
purpose of risk assessment in NCEP is not to predict
coronary atherosclerosis, but to predict CHD (particularly
acute coronary syndromes). Thus, by obscuring the mean-
ings of CAD versus CHD, they misidentify the purpose of
NCEP risk assessment for selection of patients for medical
intervention for primary prevention.
The limitations of risk assessment using standard risk
factors are well known. These are clearly laid out in reports
from the Framingham Heart Study (16) and in commen-
taries on it (18). However, Framingham risk scores have the
advantage of providing a quantitative estimate of the prob-
ability of developing CHD. For this reason, they should not
be discarded in risk assessment. Risk estimates based on
standard risk factors are the most reliable and quantitative
tool currently available for risk assessment. Indeed other
studies (19) with EBCT show that standard risk factors do
in fact have predictive power for coronary atherosclerosis,
although risk factors are not used for this purpose in clinical
practice.
A major question regarding coronary calcium is whether
estimates add independently to risk prediction beyond the
standard risk factors. Efforts to short-circuit risk assessment
using only coronary calcium scores appear to be ill advised.
Failure to use the Framingham approach throws away
valuable predictive information. To date and to my knowl-
edge, the ability of coronary calcium scores to predict acute
coronary syndromes independently of the risk factors has
not been determined. Thus, to use coronary calcium scores
as the sole method for estimating risk for acute coronary
syndromes cannot be justified at present. Certainly a more
attractive approach is to combine the use of standard risk
factors and subclinical atherosclerosis in a manner to im-
prove risk assessment.
As noted before, some investigators (15) hold that mea-
sures of subclinical atherosclerosis should not be employed
in risk assessment until more research is done to define
precisely the predictive power of measurements, indepen-
dent of standard risk factors. To obtain this information, it
would be necessary to carry out prospective studies in which
coronary calcium score is measured along with other risk
factors. In other words, it has been suggested that we need
a new Framingham study in which coronary calcium scores
are included along with standard risk factors. Unfortunately,
such a study is now unethical to carry out. The need to
intervene clinically on standard risk factors is so well
established that allowing them to go untreated for many
years is not acceptable. Wrongly perhaps some workers
believe it is unethical not to tell volunteers their coronary
calcium scores in prospective studies. Regardless, for these
reasons, it is not possible to carry out a Framingham study
including coronary calcium in prospective studies. Other
ways must be sought to integrate standard risk factors with
coronary calcium scores to enhance risk assessment. Addi-
tional ways therefore might be considered.
For example, I have proposed (20) that coronary calcium
scores could replace age as a risk factor in Framingham risk
assessment. Age counts as a risk factor in large part because
it is a reflection of coronary plaque burden. Without
question, coronary atherosclerosis rises with age, and the
greater the plaque burden, the greater the probability of
developing an acute coronary syndrome. However, for older
individuals, the severity of coronary atherosclerosis varies
widely. Thus, to use age as a risk factor, as a surrogate for
coronary plaque burden, applies a population trend to
individual patients. In this way its use differs from that of
the other risk factors where the severity of the risk factor is
measured specifically for individuals. Since the coronary
calcium score “individualizes” the age factor, the score could
replace age in Framingham equations. Although this usage
does not directly solve the problem of independent predic-
tive power of coronary calcium, it does allow coronary
calcium to be used in place of a risk factor that has definite
limitations when applied to individuals. Thus, use of coro-
nary calcium as a risk factor in the place of age essentially
makes use of the “lesser of two evils” in risk prediction.
Another approach is to combine coronary calcium scores
with standard risk factors to enhance predictive power. This
possibility was explored recently in the AHA’s Prevention V
conference (1). This conference sought to evaluate the role
of measures of subclinical atherosclerosis in clinical risk
prediction. One of the more creative outcomes of this
conference was the recognition that clinical risk assessment
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can separate patients into three general risk categories—
high, intermediate and low. Patients with high risk are those
with CHD and CHD risk equivalents (21). Patients with
established CHD have a risk for developing hard coronary
end points (myocardial infarction 1 coronary death) of
$2% per year (21). If patients without CHD could be
identified who have a similar risk, they could be called risk
equivalents. These patients might then be entered into a risk
reduction regimen now reserved for patients with estab-
lished CHD. Framingham risk prediction, in fact, can be
used to identify patients with a risk for hard CHD of $2%
per year (21).
Theoretically, there would be no need to measure coro-
nary calcium level in a patient whose risk for hard CHD is
$2% per year. An exception might be for older patients in
whom age per se is limited in its ability to predict future
coronary events in older persons (18). In older persons (e.g.,
$60 years), coronary calcium measurements might usefully
refine risk assessment by replacing age as a risk factor, as
described before.
Regardless, the main utility of coronary calcium scores
would be for patients who are at intermediate risk. This
category can include patients with multiple risk factors who
have a risk ,2% per year. If coronary calcium scores are
high, a patient at intermediate risk might be elevated to a
high risk status and thus be deserving of more aggressive
risk reduction therapy. To date and to my knowledge, there
are three prospective studies (22–24) with EBCT that have
recruited patients at intermediate risk. They reveal that in
such patients, the absolute risk for CHD is near to or
greater than 2% per year when coronary calcium scores are
in the highest category for age and gender (Table 1). In
other words, the finding of a high calcium score in a patient
with multiple risk factors at intermediate risk strongly
suggests that such a patient can be elevated to a high risk
category. This patient would then be a candidate for more
aggressive risk reduction therapy. Although more prospec-
tive studies are needed, the findings in Table 1 suggest one
way in which coronary calcium scores might be combined
with standard risk factors in risk assessment.
Another potential use of coronary calcium is to assist with
risk assessment in patients at uncertain risk. Examples
include young adults and postmenopausal women with
isolated hypercholesterolemia (elevated LDL cholesterol),
isolated low HDL cholesterol, elevated homocysteine or
other single risk factors that are present in severe form.
Although to my knowledge there are no prospective studies
to show the predictive power of coronary calcium scores in
such individuals, the finding of high scores would favor a
more aggressive risk reduction intervention.
These targeted approaches contrast to a more generalized
“screening” of the general public for coronary calcium
measurements. Both the AHA Prevention V report (1,2)
and the AHA/ACC report (3) on EBCT warned against
the generalized screening approach. There were two major
concerns. First, there is the potential for creating unneces-
sary concern on the part of the patient and physician,
leading to inappropriate invasive testing on coronary arter-
ies. Second, failure to integrate coronary calcium scores into
global risk assessment with standard risk factors could lead
to unnecessarily aggressive treatment of risk factors in the
absence of an accurate prediction of risk. Thus, whereas
measurement of coronary calcium score has the potential of
providing useful information in risk assessment, the poten-
tial also exists for its misuse. For this reason, the use of
coronary calcium scores in clinical practice should not go far
beyond their evidence base.
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